MoneyWorks4Me

Nectar Lifesciences informs about certificate

03 Jan 2026 Evaluate

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018., Nectar Lifesciences has informed that it enclosed a copy of the Certificate received from Kfin Technologies, Registrar and Share Transfer Agent of the Company for the quarter ended on December 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1862.00
Dr. Reddys Labs. 1210.70
Cipla 1407.70
Lupin 2111.90
Zydus Lifesciences 1179.50
View more..